Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02236767 · ClinicalTrials.gov registry record · NA
Transcranial Magnetic Stimulation Treatment of Hoarding Disorder
A NA study of Hoarding, sponsored by Hartford Hospital.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
- 1
- Study location
NCT02236767 is a NA study of Hoarding that has completed, run by Hartford Hospital. The registered enrollment target is 1 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02236767, a NA study of Hoarding, has completed, sponsored by Hartford Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
- 1
- Study location
Study Summary
This is multiple baseline study including up to three participants with a primary diagnosis of hoarding disorder. All patients will receive unblinded repetitive transcranial magnetic stimulation study intervention.
Conditions Studied
Interventions
- DEVICE Neurostar Transcranial Magnetic Stimulation Therapy System
Study Locations (1)
Connecticut
- Hartford Hospital - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2014-07 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02236767
The ClinicalTrials.gov registry entry for NCT02236767 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hartford Hospital, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hoarding appearing as the primary indexed condition, and to 1 intervention - of which Neurostar Transcranial Magnetic Stimulation Therapy System is the first listed.
NCT02236767 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT02236767 about?
NCT02236767 is a clinical study titled "Transcranial Magnetic Stimulation Treatment of Hoarding Disorder". This is multiple baseline study including up to three participants with a primary diagnosis of hoarding disorder. All patients will receive unblinded repetitive transcranial magnetic stimulation study intervention.
What is the current status of trial NCT02236767?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2014-07. Estimated completion is 2014-12.
What conditions does trial NCT02236767 study?
This clinical trial studies the following conditions: Hoarding.
What interventions are being tested in trial NCT02236767?
The interventions under investigation include: Neurostar Transcranial Magnetic Stimulation Therapy System (DEVICE).
Who is sponsoring clinical trial NCT02236767?
This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02236767 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hoarding
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.